When a Medical Billing Outsourcing Company Stops Compounding, and What to Do About It
SRF Capital Studio Research DeskFunding Intelligence, SRF Capital StudioA mid-size Indian RCM company built on coding and billing seats will keep growing for a while and then stop compounding. The moves that change the trajectory, and the checks a hospital should run before outsourcing.
Summary
- A medical billing outsourcing firm that grows by adding coders and billers will see revenue rise and margins fall as wages climb, clients ask for AI pricing and larger platforms compete for renewals.
- Four moves change the trajectory: build clinical documentation capability, price part of the work on outcomes, invest in the security proof large buyers require, and specialise where scale alone cannot win.
- Hospitals weighing medical billing outsourcing should buy the same thing these firms should sell: measured results, not seats.
Take a hypothetical but familiar company. It has built ₹150 crore of revenue over fifteen years, doing coding, billing and accounts receivable follow-up for US physician groups and a few hospitals. It employs several hundred certified coders, has twenty or thirty clients on multi-year contracts, earns a respectable margin and grows in the mid-teens.
By the standards of Indian services businesses it has arrived. It is also, in our view, at the start of a plateau, and the next five years depend on whether its founders see it.
Why the model stops compounding
Nothing dramatic happens. The business keeps adding clients and people. What changes is the arithmetic underneath.
Routine work is being re-priced
Software now suggests codes for simple outpatient charts, checks claims before submission and posts payments. Clients know what these tools can do and are asking for the savings in their renewal price. A firm whose revenue is mostly routine work billed per chart or per hour will see its unit price fall even as volumes hold.
Wages rise faster than contract escalators
Experienced coders and analysts are in demand across the industry, and every one who leaves takes client knowledge with them. Few mid-size firms measure the full cost of replacing a coder: recruitment, credential checks, client-specific training and months of lower accuracy. Measured honestly, attrition is often the largest cost that never appears as a line in the P&L.
Larger competitors want the same clients
The large Indian-origin operators are now owned by global private , with budgets for automation and acquisitions. Our piece on RCM companies in India and their deals lists who owns whom. These platforms can bundle coding, documentation, denial work and analytics, and can price hard for renewals they want.
Put together, the likely path for our hypothetical firm is revenue that keeps rising, margin that slowly erodes, and a valuation that stays tied to headcount. That is not a crisis. It is a slow loss of options.
A services business that grows revenue and headcount at the same rate is not scaling. It is only getting bigger.
Four moves that change the trajectory
1. Build clinical documentation capability
Clinical documentation improvement (CDI) means reviewing inpatient records before coding, finding where the notes understate the patient's condition, and querying the doctor. It needs clinically trained people with coding knowledge, and it is paid for by the revenue it supports, which makes it far harder to commoditise than routine coding.
The practical start is inside the firm. Many mid-size operators already employ experienced inpatient coders with clinical degrees who can be trained and certified for documentation work. Run a first cohort, offer a pilot to an existing hospital client on terms that let you measure the result, and use the documented outcome to sell the second engagement at full price.
2. Price part of the work on outcomes
Denial recovery is the natural place to start. Instead of a monthly fee per account, charge a share of what you recover. Worked examples in circulation often assume contingency fees of 25% or more on very large denial pools, which produce fee income from one client larger than a mid-size firm's entire revenue. A more modest illustration is closer to what a firm of this size would see.
Fixed fee versus outcome fee on one denial account (illustrative)
| Line | Illustrative value |
|---|---|
| Denied claims handed over by one US client each month | USD 1 million |
| Share recovered by the vendor | 60% |
| Money recovered for the client | USD 600,000 |
| Vendor fee at an assumed 10% of recovery | USD 60,000 a month |
| Same account on a fixed monthly fee (assumed) | USD 35,000 a month |
The point is not the specific figures. It is that outcome pricing ties revenue to results the vendor controls, and makes the vendor's recovery rate its most valuable asset. Before proposing it, track your actual recovery rate and time-to-recovery by payer for at least a quarter. If the numbers are weak, fix the process first; outcome pricing on a weak operation just transfers risk to yourself.
3. Invest in proof, not only delivery
Large US health systems vet vendors' security and compliance before they will sign, and certifications such as HITRUST CSF are a common requirement. In India, the Digital Personal Data Protection Rules notified in November 2025 apply in full from May 2027, with penalties up to ₹250 crore for failures to keep reasonable security safeguards. For a firm handling patient records, this is sales infrastructure: without it, whole categories of client are closed.
Proof also means client reporting. Dashboards showing each client's AR days, clean claim rate and denial rate, before and after you took over, are the most persuasive sales document an RCM firm can have. The KPIs to report are the same ones a hospital CFO should track.
4. Specialise where scale does not win
A mid-size firm cannot out-spend a private-equity platform across every service. It can know one specialty, one payer segment or one kind of client far better. Oncology or cardiology coding, a particular state's Medicaid rules, or ambulatory surgery centres are the kind of niche where depth beats size, and specialists are the firms platforms most often want to buy.
Sequencing
These moves compete for the same management time and cash, so order matters. We would start with measurement, because every other move depends on it: recovery rates by payer, revenue by service line, costed attrition, client-level results. Documentation capability and security certification take the longest to build, so they should begin early and run in parallel. Outcome pricing comes once the data proves the recovery rate. Specialisation is a strategic choice that should shape all of the above, not a fifth project.
If you are weighing these choices against a possible sale or raise, our strategy consulting practice works through exactly this sequencing with services founders.
If you are a hospital thinking about medical billing outsourcing
The same logic applies from the other side of the table. Indian hospitals increasingly consider outsourcing billing, insurance desk and TPA follow-up, and most vendors will offer them seats. Ask for something else.
- Measure first. Know your AR days, deduction rate and discharge-to-claim time by payer before inviting bids. Otherwise no vendor can be held to anything.
- Buy outcomes. Ask vendors to commit to lower deductions and faster settlement, with part of the fee tied to both. IRDAI's one-hour cashless and three-hour discharge clocks give you a clear operational target.
- Keep the data. The claims history, deduction reasons and payer correspondence must stay yours, in a form you can take to another vendor.
- Check the security. A vendor handling patient records carries data-protection liability that lands on you too.
For the full picture of how the cycle works and where the money leaks, start with our revenue cycle management report and the denial management guide.
Medical billing outsourcing works for both sides when it is bought and sold as a result. The firms that make that shift in the next few years will set the terms; the rest will be priced by those who did.
How useful was this article?
One tap. It tells us what to write more of.
About the author
SRF Capital Studio Research Desk
Funding Intelligence, SRF Capital Studio
The next one
Get what we publish next, by email.
Working notes on raising, borrowing, protecting, growing and structuring capital in India. One email a week at most, and you can leave any time.
We use your address only to send this. See our privacy policy.
We store your address to send you these emails and nothing else. See our privacy policy.